A prospective, multicenter trial of low-intensity focused ultrasound (LIFU) for blood-brain barrier disruption for liquid biopsy in glioblastoma (LIBERATE).
Manmeet S. Ahluwalia(Baptist Hospital of Miami), Graeme F. Woodworth(West Virginia University), Nduka Amankulor(University of Pennsylvania), Arjun Sahgal(Sunnybrook Health Science Centre), Richard G. Everson, Alon Y. Mogilner(NYU Langone Health), Christopher P. Cifarelli(West Virginia University), Justin Sporrer(Baptist Hospital of Miami), Mark V. Mishra(University of Maryland, Baltimore), Theodore H. Schwartz(Johns Hopkins University), Ali R. Rezai(West Virginia University), Bhavya Shah(Southwestern Medical Center), Achal S. Achrol(Institute for Stem Cell Biology and Regenerative Medicine), Nir Lipsman(Sunnybrook Health Science Centre), Chetan Bettegowda(Johns Hopkins University), Michael McDermott(Baptist Health South Florida), Toral Patel(The University of Texas Southwestern Medical Center), Terry C. Burns(Neurological Surgery), John Frederick De Groot(University of California, San Francisco), Ahmad Ozair(King George's Medical University)
Cited by 9
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k